The funding will support Aspen’s capabilities to manufacture routine and outbreak vaccines for Africa
The international multidisciplinary consortium comprising Bharat Biotech International, the University of Sydney and ExcellGene SA, Switzerland will receive funding of $19.3 million to support the development of a ‘variant-proof’ coronavirus vaccine candidate.
Betacoronaviruses are being seen as a major threat to humanity and the current way of life and public health experts feel that vaccines could be a crucial tool to fight them as they emerge.
State-run Coal India today blamed adverse weather for its inability to meet production targets in the first half of the 2011-12 financial year, with output falling short of the mark by about 20 million tonnes.
The country's domestic coal production target could not be achieved in 2010-11 mainly on account of environment ministry not allowing the expansion of projects falling in areas categorised as critically polluted under CEPI, Parliament was informed today.
Speaking to CNBC-TV18, Chairman Partha S Bhattacharyya confirmed fears that the company may end with the lower than targetted 460 million tonne for the current fiscal.